Loading...
Header Logo
Keywords
Last Name
Institution

Dr Peter Vickerman

Title[no position]
Institution[no institution name]
Address[no address]
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Hickman M, De Angelis D, Vickerman P, Hutchinson S, Martin NK. Hepatitis C virus treatment as prevention in people who inject drugs: testing the evidence. Curr Opin Infect Dis. 2015 Dec; 28(6):576-82. PMID: 26524330.
      View in: PubMed
    2. Looker KJ, Magaret AS, May MT, Turner KM, Vickerman P, Gottlieb SL, Newman LM. Global and Regional Estimates of Prevalent and Incident Herpes Simplex Virus Type 1 Infections in 2012. PLoS One. 2015; 10(10):e0140765. PMID: 26510007.
      View in: PubMed
    3. Mitchell KM, Lépine A, Terris-Prestholt F, Torpey K, Khamofu H, Folayan MO, Musa J, Anenih J, Sagay AS, Alhassan E, Idoko J, Vickerman P. Modelling the impact and cost-effectiveness of combination prevention amongst HIV serodiscordant couples in Nigeria. AIDS. 2015 Sep 24; 29(15):2035-44. PMID: 26355574.
      View in: PubMed
    4. Martin NK, Vickerman P, Dore GJ, Hickman M. The hepatitis C virus epidemics in key populations (including people who inject drugs, prisoners and MSM): the use of direct-acting antivirals as treatment for prevention. Curr Opin HIV AIDS. 2015 Sep; 10(5):374-80. PMID: 26248124.
      View in: PubMed
    5. Meyer-Rath G, Pienaar J, Brink B, van Zyl A, Muirhead D, Grant A, Churchyard G, Watts C, Vickerman P. The Impact of Company-Level ART Provision to a Mining Workforce in South Africa: A Cost-Benefit Analysis. PLoS Med. 2015 Sep; 12(9):e1001869. PMID: 26327271.
      View in: PubMed
    6. Mumtaz GR, Weiss HA, Vickerman P, Larke N, Abu-Raddad LJ. Using hepatitis C prevalence to estimate HIV epidemic potential among people who inject drugs in the Middle East and North Africa. AIDS. 2015 Aug 24; 29(13):1701-10. PMID: 26372281.
      View in: PubMed
    7. Scott N, McBryde E, Vickerman P, Martin NK, Stone J, Drummer H, Hellard M. The role of a hepatitis C virus vaccine: modelling the benefits alongside direct-acting antiviral treatments. BMC Med. 2015 Aug 20; 13:198. PMID: 26289050.
      View in: PubMed
    8. Hickman M, Vickerman P, Degenhardt L. Editorial Commentary: The Impact of Opiate Substitution Therapy and Highly Active Antiretroviral Therapy on Mortality Risk Among People Who Inject Drugs. Clin Infect Dis. 2015 Oct 01; 61(7):1166-8. PMID: 26113654.
      View in: PubMed
    9. Looker KJ, Magaret AS, Turner KM, Vickerman P, Gottlieb SL, Newman LM. Correction: Global estimates of prevalent and incident herpes simplex virus type 2 infections in 2012. PLoS One. 2015; 10(5):e0128615. PMID: 25992922.
      View in: PubMed
    10. Terris-Prestholt F, Vickerman P, Torres-Rueda S, Santesso N, Sweeney S, Mallma P, Shelley KD, Garcia PJ, Bronzan R, Gill MM, Broutet N, Wi T, Watts C, Mabey D, Peeling RW, Newman L. The cost-effectiveness of 10 antenatal syphilis screening and treatment approaches in Peru, Tanzania, and Zambia. Int J Gynaecol Obstet. 2015 Jun; 130 Suppl 1:S73-80. PMID: 25963907.
      View in: PubMed
    11. Tavitian-Exley I, Vickerman P, Bastos FI, Boily MC. Influence of different drugs on HIV risk in people who inject: systematic review and meta-analysis. Addiction. 2015 Apr; 110(4):572-84. PMID: 25582153.
      View in: PubMed
    12. Sacks-Davis R, McBryde E, Grebely J, Hellard M, Vickerman P. Many hepatitis C reinfections that spontaneously clear may be undetected: Markov-chain Monte Carlo analysis of observational study data. J R Soc Interface. 2015 Mar 06; 12(104):20141197. PMID: 25589564.
      View in: PubMed
    13. Rhodes T, Guise A, Ndimbii J, Strathdee S, Ngugi E, Platt L, Kurth A, Cleland C, Vickerman P. Is the promise of methadone Kenya's solution to managing HIV and addiction? A mixed-method mathematical modelling and qualitative study. BMJ Open. 2015 Mar 06; 5(3):e007198. PMID: 25748417.
      View in: PubMed
    14. Low A, Nagot N, Konate I, Meda N, Segondy M, Van de Perre P, Mayaud P, Vickerman P. Potential impact of existing interventions and of antiretroviral use in female sex workers on transmission of HIV in Burkina Faso: a modeling study. J Acquir Immune Defic Syndr. 2015 Mar 01; 68 Suppl 2:S180-8. PMID: 25723983.
      View in: PubMed
    15. Boily MC, Pickles M, Alary M, Baral S, Blanchard J, Moses S, Vickerman P, Mishra S. What really is a concentrated HIV epidemic and what does it mean for West and Central Africa? Insights from mathematical modeling. J Acquir Immune Defic Syndr. 2015 Mar 01; 68 Suppl 2:S74-82. PMID: 25723994.
      View in: PubMed
    16. Looker KJ, Magaret AS, Turner KM, Vickerman P, Gottlieb SL, Newman LM. Global estimates of prevalent and incident herpes simplex virus type 2 infections in 2012. PLoS One. 2015; 10(1):e114989. PMID: 25608026.
      View in: PubMed
    17. Mitchell KM, Foss AM, Ramesh BM, Washington R, Isac S, Prudden HJ, Deering KN, Blanchard JF, Moses S, Lowndes CM, Boily MC, Alary M, Vickerman P. Relationship between exposure to the Avahan intervention and levels of reported condom use among men who have sex with men in southern India. BMC Public Health. 2014 Dec 04; 14:1245. PMID: 25476231.
      View in: PubMed
    18. Vickerman P, Page K, Maher L, Hickman M. Commentary on Nolan et al. (2014): Opiate substitution treatment and hepatitis C virus prevention: building an evidence base? Addiction. 2014 Dec; 109(12):2060-1. PMID: 25384936.
      View in: PubMed
    19. Vickerman P, Platt L, Jolley E, Rhodes T, Kazatchkine MD, Latypov A. Controlling HIV among people who inject drugs in Eastern Europe and Central Asia: insights from modeling. Int J Drug Policy. 2014 Nov; 25(6):1163-73. PMID: 25449056.
      View in: PubMed
    20. Vassall A, Chandrashekar S, Pickles M, Beattie TS, Shetty G, Bhattacharjee P, Boily MC, Vickerman P, Bradley J, Alary M, Moses S. Community mobilisation and empowerment interventions as part of HIV prevention for female sex workers in Southern India: a cost-effectiveness analysis. PLoS One. 2014; 9(10):e110562. PMID: 25333501.
      View in: PubMed
    21. Martin NK, Foster GR, Vilar J, Ryder S, Cramp ME, Gordon F, Dillon JF, Craine N, Busse H, Clements A, Hutchinson SJ, Ustianowski A, Ramsay M, Goldberg DJ, Irving W, Hope V, De Angelis D, Lyons M, Vickerman P, Hickman M. HCV treatment rates and sustained viral response among people who inject drugs in seven UK sites: real world results and modelling of treatment impact. J Viral Hepat. 2015 Apr; 22(4):399-408. PMID: 25288193.
      View in: PubMed
    22. Panovska-Griffiths J, Vassall A, Prudden HJ, Lépine A, Boily MC, Chandrashekar S, Mitchell KM, Beattie TS, Alary M, Martin NK, Vickerman P. Optimal allocation of resources in female sex worker targeted HIV prevention interventions: model insights from Avahan in South India. PLoS One. 2014; 9(10):e107066. PMID: 25271808.
      View in: PubMed
    23. Hickman M, Martin N, Vickerman P, Hutchinson S. Strategies to reduce HCV disease burden and HCV transmission need different models, as what works for end-stage liver disease may not work for HCV prevalence: a comment on the results presented in JVH Special Issue. J Viral Hepat. 2014 Dec; 21(12):e167-8. PMID: 25262826.
      View in: PubMed
    24. Mountain E, Mishra S, Vickerman P, Pickles M, Gilks C, Boily MC. Antiretroviral therapy uptake, attrition, adherence and outcomes among HIV-infected female sex workers: a systematic review and meta-analysis. PLoS One. 2014; 9(9):e105645. PMID: 25265158.
      View in: PubMed
    25. Lazarus JV, Lundgren J, Casabona J, Wiessing L, Matheï C, Vickerman P, Prins M, Kretzschmar M, Kantzanou M, Giraudon I, Ferri M, Griffiths P, Harris M, Walker M, Chavdarova L, Schatz E, Schiffer K, Kools J, Farell J, Mendão L. Roundtable discussion: how lessons learned from HIV can inform the global response to viral hepatitis. BMC Infect Dis. 2014; 14 Suppl 6:S18. PMID: 25252919.
      View in: PubMed
    26. Chandrashekar S, Guinness L, Pickles M, Shetty GY, Alary M, Vickerman P. The costs of scaling up HIV prevention for high risk groups: lessons learned from the Avahan Programme in India. PLoS One. 2014; 9(9):e106582. PMID: 25203052.
      View in: PubMed
    27. Mountain E, Pickles M, Mishra S, Vickerman P, Alary M, Boily MC. The HIV care cascade and antiretroviral therapy in female sex workers: implications for HIV prevention. Expert Rev Anti Infect Ther. 2014 Oct; 12(10):1203-19. PMID: 25174997.
      View in: PubMed
    28. Vassall A, Pickles M, Chandrashekar S, Boily MC, Shetty G, Guinness L, Lowndes CM, Bradley J, Moses S, Alary M. Cost-effectiveness of HIV prevention for high-risk groups at scale: an economic evaluation of the Avahan programme in south India. Lancet Glob Health. 2014 Sep; 2(9):e531-e540. PMID: 25304420.
      View in: PubMed
    29. Wiessing L, Ferri M, Grady B, Kantzanou M, Sperle I, Cullen KJ. Hepatitis C virus infection epidemiology among people who inject drugs in Europe: a systematic review of data for scaling up treatment and prevention. PLoS One. 2014; 9(7):e103345. PMID: 25068274.
      View in: PubMed
    30. Martin NK, Vickerman P, Goldberg D, Hickman M. HCV treatment as prevention in prison: key issues. Hepatology. 2015 Jan; 61(1):402-3. PMID: 24797358.
      View in: PubMed
    31. Cianci F, Sweeney S, Konate I, Nagot N, Low A, Mayaud P, Vickerman P. The cost of providing combined prevention and treatment services, including ART, to female sex workers in Burkina Faso. PLoS One. 2014; 9(6):e100107. PMID: 24950185.
      View in: PubMed
    32. Beattie TS, Mohan HL, Bhattacharjee P, Chandrashekar S, Isac S, Wheeler T, Prakash R, Ramesh BM, Blanchard JF, Heise L, Vickerman P, Moses S, Watts C. Community mobilization and empowerment of female sex workers in Karnataka State, South India: associations with HIV and sexually transmitted infection risk. Am J Public Health. 2014 Aug; 104(8):1516-25. PMID: 24922143.
      View in: PubMed
    33. Lépine A, Terris-Prestholt F, Vickerman P. Determinants of HIV testing among Nigerian couples: a multilevel modelling approach. Health Policy Plan. 2015 Jun; 30(5):579-92. PMID: 24906362.
      View in: PubMed
    34. Mitchell KM, Foss AM, Prudden HJ, Mukandavire Z, Pickles M, Williams JR, Johnson HC, Ramesh BM, Washington R, Isac S, Rajaram S, Phillips AE, Bradley J, Alary M, Moses S, Lowndes CM, Watts CH, Boily MC, Vickerman P. Who mixes with whom among men who have sex with men? Implications for modelling the HIV epidemic in southern India. J Theor Biol. 2014 Aug 21; 355:140-50. PMID: 24727187.
      View in: PubMed
    35. Low AJ, Konate I, Nagot N, Weiss HA, Kania D, Vickerman P, Segondy M, Mabey D, Pillay D, Meda N, van de Perre P, Mayaud P. Cervicovaginal HIV-1 shedding in women taking antiretroviral therapy in Burkina Faso: a longitudinal study. J Acquir Immune Defic Syndr. 2014 Feb 01; 65(2):237-45. PMID: 24226060.
      View in: PubMed
    36. Terris-Prestholt F, Foss AM, Cox AP, Heise L, Meyer-Rath G, Delany-Moretlwe S, Mertenskoetter T, Rees H, Vickerman P, Watts CH. Cost-effectiveness of tenofovir gel in urban South Africa: model projections of HIV impact and threshold product prices. BMC Infect Dis. 2014 Jan 09; 14:14. PMID: 24405719.
      View in: PubMed
    37. Mishra S, Mountain E, Pickles M, Vickerman P, Shastri S, Gilks C, Dhingra NK, Washington R, Becker ML, Blanchard JF, Alary M, Boily MC. Exploring the population-level impact of antiretroviral treatment: the influence of baseline intervention context. AIDS. 2014 Jan; 28 Suppl 1:S61-72. PMID: 24468948.
      View in: PubMed
    38. Martin NK, Devine A, Eaton JW, Miners A, Hallett TB, Foster GR, Dore GJ, Easterbrook PJ, Legood R, Vickerman P. Modeling the impact of early antiretroviral therapy for adults coinfected with HIV and hepatitis B or C in South Africa. AIDS. 2014 Jan; 28 Suppl 1:S35-46. PMID: 24468945.
      View in: PubMed
    39. Terris-Prestholt F, Hanson K, MacPhail C, Vickerman P, Rees H, Watts C. How much demand for New HIV prevention technologies can we really expect? Results from a discrete choice experiment in South Africa. PLoS One. 2013; 8(12):e83193. PMID: 24386160.
      View in: PubMed
    40. Vassall A, Remme M, Watts C, Hallett T, Siapka M, Vickerman P, Terris-Prestholt F, Haacker M, Heise L, Haines A, Atun R, Piot P. Financing essential HIV services: a new economic agenda. PLoS Med. 2013 Dec; 10(12):e1001567. PMID: 24358028.
      View in: PubMed
    41. Low AJ, Konate I, Nagot N, Weiss HA, Mabey D, Segondy M, Vickerman P, Meda N, van de Perre P, Mayaud P. Neisseria gonorrhoeae and Chlamydia trachomatis infection in HIV-1-infected women taking antiretroviral therapy: a prospective cohort study from Burkina Faso. Sex Transm Infect. 2014 Mar; 90(2):100-3. PMID: 24337732.
      View in: PubMed
    42. Eaton JW, Menzies NA, Stover J, Cambiano V, Chindelevitch L, Cori A, Hontelez JA, Humair S, Kerr CC, Klein DJ, Mishra S, Mitchell KM, Nichols BE, Vickerman P, Bakker R, Bärnighausen T, Bershteyn A, Bloom DE, Boily MC, Chang ST, Cohen T, Dodd PJ, Fraser C, Gopalappa C, Lundgren J, Martin NK, Mikkelsen E, Mountain E, Pham QD, Pickles M, Phillips A, Platt L, Pretorius C, Prudden HJ, Salomon JA, van de Vijver DA, de Vlas SJ, Wagner BG, White RG, Wilson DP, Zhang L, Blandford J, Meyer-Rath G, Remme M, Revill P, Sangrujee N, Terris-Prestholt F, Doherty M, Shaffer N, Easterbrook PJ, Hirnschall G, Hallett TB. Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models. Lancet Glob Health. 2014 Jan; 2(1):e23-34. PMID: 25104632.
      View in: PubMed
    43. Miners AH, Martin NK, Ghosh A, Hickman M, Vickerman P. Assessing the cost-effectiveness of finding cases of hepatitis C infection in UK migrant populations and the value of further research. J Viral Hepat. 2014; 21(9):616-23. PMID: 24215210.
      View in: PubMed
    44. Martin TC, Martin NK, Hickman M, Vickerman P, Page EE, Everett R, Gazzard BG, Nelson M. Hepatitis C virus reinfection incidence and treatment outcome among HIV-positive MSM. AIDS. 2013 Oct 23; 27(16):2551-7. PMID: 23736152.
      View in: PubMed
    45. Prudden HJ, Watts CH, Vickerman P, Bobrova N, Heise L, Ogungbemi MK, Momah A, Blanchard JF, Foss AM. Can the UNAIDS modes of transmission model be improved? A comparison of the original and revised model projections using data from a setting in west Africa. AIDS. 2013 Oct 23; 27(16):2623-35. PMID: 23921619.
      View in: PubMed
    46. Pickles M, Boily MC, Vickerman P, Lowndes CM, Moses S, Blanchard JF, Deering KN, Bradley J, Ramesh BM, Washington R, Adhikary R, Mainkar M, Paranjape RS, Alary M. Assessment of the population-level effectiveness of the Avahan HIV-prevention programme in South India: a preplanned, causal-pathway-based modelling analysis. Lancet Glob Health. 2013 Nov; 1(5):e289-99. PMID: 25104493.
      View in: PubMed
    47. Martin NK, Vickerman P, Grebely J, Hellard M, Hutchinson SJ, Lima VD, Foster GR, Dillon JF, Goldberg DJ, Dore GJ, Hickman M. Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals. Hepatology. 2013 Nov; 58(5):1598-609. PMID: 23553643.
      View in: PubMed
    48. Martin NK, Hickman M, Miners A, Hutchinson SJ, Taylor A, Vickerman P. Cost-effectiveness of HCV case-finding for people who inject drugs via dried blood spot testing in specialist addiction services and prisons. BMJ Open. 2013 Aug 13; 3(8). PMID: 23943776.
      View in: PubMed
    49. Martin NK, Hickman M, Hutchinson SJ, Goldberg DJ, Vickerman P. Combination interventions to prevent HCV transmission among people who inject drugs: modeling the impact of antiviral treatment, needle and syringe programs, and opiate substitution therapy. Clin Infect Dis. 2013 Aug; 57 Suppl 2:S39-45. PMID: 23884064.
      View in: PubMed
    50. Vickerman P, Hickman M. Commentary on de Vos et al. (2013): can ecological trends in HIV or HCV incidence be used to assess intervention impact? Addiction. 2013 Jun; 108(6):1082-3. PMID: 23659844.
      View in: PubMed
    51. Boily MC, Pickles M, Lowndes CM, Ramesh BM, Washington R, Moses S, Deering KN, Mitchell KM, Reza-Paul S, Blanchard J, Vassall A, Alary M, Vickerman P. Positive impact of a large-scale HIV prevention programme among female sex workers and clients in South India. AIDS. 2013 Jun 01; 27(9):1449-60. PMID: 23462221.
      View in: PubMed
    52. Mills HL, White E, Colijn C, Vickerman P, Heimer R. HIV transmission from drug injectors to partners who do not inject, and beyond: modelling the potential for a generalized heterosexual epidemic in St. Petersburg, Russia. Drug Alcohol Depend. 2013 Nov 01; 133(1):242-7. PMID: 23692991.
      View in: PubMed
    53. Martin NK, Vickerman P, Miners A, Hickman M. How cost-effective is hepatitis C virus treatment for people who inject drugs? J Gastroenterol Hepatol. 2013 Apr; 28(4):590-2. PMID: 23527756.
      View in: PubMed
    54. Vickerman P, Martin NK, Roy A, Beattie T, Jarlais DD, Strathdee S, Wiessing L, Hickman M. Is the HCV-HIV co-infection prevalence amongst injecting drug users a marker for the level of sexual and injection related HIV transmission? Drug Alcohol Depend. 2013 Sep 01; 132(1-2):172-81. PMID: 23453261.
      View in: PubMed
    55. Deering KN, Vickerman P, Pickles M, Moses S, Blanchard JF, Ramesh BM, Isac S, Boily MC. Differences between seven measures of self-reported numbers of clients of female sex workers in southern India: implications for individual- and population-level analysis. AIDS Behav. 2013 Feb; 17(2):649-61. PMID: 22886176.
      View in: PubMed
    56. Mitchell KM, Cox AP, Mabey D, Tucker JD, Peeling RW, Vickerman P. The impact of syphilis screening among female sex workers in China: a modelling study. PLoS One. 2013; 8(1):e55622. PMID: 23383249.
      View in: PubMed
    57. Tan NX, Rydzak C, Yang LG, Vickerman P, Yang B, Peeling RW, Hawkes S, Chen XS, Tucker JD. Prioritizing congenital syphilis control in south China: a decision analytic model to inform policy implementation. PLoS Med. 2013; 10(1):e1001375. PMID: 23349624.
      View in: PubMed
    58. Castro Sanchez AY, Aerts M, Shkedy Z, Vickerman P, Faggiano F, Salamina G, Hens N. A mathematical model for HIV and hepatitis C co-infection and its assessment from a statistical perspective. Epidemics. 2013 Mar; 5(1):56-66. PMID: 23438431.
      View in: PubMed
    59. Vickerman P, Martin NK, Hickman M. Could low dead-space syringes really reduce HIV transmission to low levels? Int J Drug Policy. 2013 Jan; 24(1):8-14. PMID: 23206493.
      View in: PubMed
    60. MacArthur GJ, Minozzi S, Martin N, Vickerman P, Deren S, Bruneau J, Degenhardt L, Hickman M. Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis. BMJ. 2012 Oct 03; 345:e5945. PMID: 23038795.
      View in: PubMed
    61. Vickerman P, Martin N, Turner K, Hickman M. Can needle and syringe programmes and opiate substitution therapy achieve substantial reductions in hepatitis C virus prevalence? Model projections for different epidemic settings. Addiction. 2012 Nov; 107(11):1984-95. PMID: 22564041.
      View in: PubMed
    62. Delva W, Eaton JW, Meng F, Fraser C, White RG, Vickerman P, Boily MC, Hallett TB. HIV treatment as prevention: optimising the impact of expanded HIV treatment programmes. PLoS Med. 2012; 9(7):e1001258. PMID: 22802738.
      View in: PubMed
    63. Mills HL, Colijn C, Vickerman P, Leslie D, Hope V, Hickman M. Respondent driven sampling and community structure in a population of injecting drug users, Bristol, UK. Drug Alcohol Depend. 2012 Dec 01; 126(3):324-32. PMID: 22728045.
      View in: PubMed
    64. Hellard ME, Jenkinson R, Higgs P, Stoové MA, Sacks-Davis R, Gold J, Hickman M, Vickerman P, Martin NK. Modelling antiviral treatment to prevent hepatitis C infection among people who inject drugs in Victoria, Australia. Med J Aust. 2012 Jun 04; 196(10):638-41. PMID: 22676879.
      View in: PubMed
    65. Vickerman P, Grebely J, Dore GJ, Sacks-Davis R, Page K, Thomas DL, Osburn WO, Cox AL, Aitken CK, Hickman M, Hellard M. The more you look, the more you find: effects of hepatitis C virus testing interval on reinfection incidence and clearance and implications for future vaccine study design. J Infect Dis. 2012 May 01; 205(9):1342-50. PMID: 22457292.
      View in: PubMed
    66. Hickman M, Vickerman P, Degenhardt L. Commentary on Mehta et al. (2012): Natural history of injecting drug use. Addiction. 2012 Feb; 107(2):359-60. PMID: 22248140.
      View in: PubMed
    67. Chandrashekar S, Vassall A, Reddy B, Shetty G, Vickerman P, Alary M. The costs of HIV prevention for different target populations in Mumbai, Thane and Bangalore. BMC Public Health. 2011 Dec 29; 11 Suppl 6:S7. PMID: 22375837.
      View in: PubMed
    68. Deering KN, Boily MC, Lowndes CM, Shoveller J, Tyndall MW, Vickerman P, Bradley J, Gurav K, Pickles M, Moses S, Ramesh BM, Washington R, Rajaram S, Alary M. A dose-response relationship between exposure to a large-scale HIV preventive intervention and consistent condom use with different sexual partners of female sex workers in southern India. BMC Public Health. 2011 Dec 29; 11 Suppl 6:S8. PMID: 22375863.
      View in: PubMed
    69. Martin NK, Vickerman P, Miners A, Foster GR, Hutchinson SJ, Goldberg DJ, Hickman M. Cost-effectiveness of hepatitis C virus antiviral treatment for injection drug user populations. Hepatology. 2012 Jan; 55(1):49-57. PMID: 21898506.
      View in: PubMed
    70. Vickerman P, Martin NK, Hickman M. Understanding the trends in HIV and hepatitis C prevalence amongst injecting drug users in different settings--implications for intervention impact. Drug Alcohol Depend. 2012 Jun 01; 123(1-3):122-31. PMID: 22138540.
      View in: PubMed
    71. Turner KM, Hutchinson S, Vickerman P, Hope V, Craine N, Palmateer N, May M, Taylor A, De Angelis D, Cameron S, Parry J, Lyons M, Goldberg D, Allen E, Hickman M. The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence. Addiction. 2011 Nov; 106(11):1978-88. PMID: 21615585.
      View in: PubMed
    72. Martin NK, Pitcher AB, Vickerman P, Vassall A, Hickman M. Optimal control of hepatitis C antiviral treatment programme delivery for prevention amongst a population of injecting drug users. PLoS One. 2011; 6(8):e22309. PMID: 21853030.
      View in: PubMed
    73. Hickman M, Vickerman P, Robertson R, Macleod J, Strang J. Promoting recovery and preventing drug-related mortality: competing risks? J Public Health (Oxf). 2011 Sep; 33(3):332-4. PMID: 21788295.
      View in: PubMed
    74. Cox AP, Foss AM, Shafer LA, Nsubuga RN, Vickerman P, Hayes RJ, Watts C, White RG. Attaining realistic and substantial reductions in HIV incidence: model projections of combining microbicide and male circumcision interventions in rural Uganda. Sex Transm Infect. 2011 Dec; 87(7):635-9. PMID: 21768615.
      View in: PubMed
    75. Vickerman P, Devine A, Foss AM, Delany-Moretlwe S, Mayaud P, Meyer-Rath G. The cost-effectiveness of herpes simplex virus-2 suppressive therapy with daily aciclovir for delaying HIV disease progression among HIV-1-infected women in South Africa. Sex Transm Dis. 2011 May; 38(5):401-9. PMID: 21317689.
      View in: PubMed
    76. Martin NK, Vickerman P, Foster GR, Hutchinson SJ, Goldberg DJ, Hickman M. Can antiviral therapy for hepatitis C reduce the prevalence of HCV among injecting drug user populations? A modeling analysis of its prevention utility. J Hepatol. 2011 Jun; 54(6):1137-44. PMID: 21145810.
      View in: PubMed
    77. Martin NK, Vickerman P, Hickman M. Mathematical modelling of hepatitis C treatment for injecting drug users. J Theor Biol. 2011 Apr 07; 274(1):58-66. PMID: 21236265.
      View in: PubMed
    78. Watts C, Zimmerman C, Foss AM, Hossain M, Cox A, Vickerman P. Remodelling core group theory: the role of sustaining populations in HIV transmission. Sex Transm Infect. 2010 Dec; 86 Suppl 3:iii85-92. PMID: 21098061.
      View in: PubMed
    79. Foss AM, Vickerman PT, Mayaud P, Weiss HA, Ramesh BM, Reza-Paul S, Washington R, Blanchard J, Moses S, Lowndes CM, Alary M, Watts CH. Modelling the interactions between herpes simplex virus type 2 and HIV: implications for the HIV epidemic in southern India. Sex Transm Infect. 2011 Feb; 87(1):22-7. PMID: 21059838.
      View in: PubMed
    80. Cornish R, Macleod J, Strang J, Vickerman P, Hickman M. Risk of death during and after opiate substitution treatment in primary care: prospective observational study in UK General Practice Research Database. BMJ. 2010 Oct 26; 341:c5475. PMID: 20978062.
      View in: PubMed
    81. Vickerman P, Foss AM, Pickles M, Deering K, Verma S. To what extent is the HIV epidemic in southern India driven by commercial sex? A modelling analysis. AIDS. 2010 Oct 23; 24(16):2563-72. PMID: 20852405.
      View in: PubMed
    82. Vickerman P, Martin N, Hickman M. Can Hepatitis C virus treatment be used as a prevention strategy? Additional model projections for Australia and elsewhere. Drug Alcohol Depend. 2011 Jan 15; 113(2-3):83-5; discussion 86-7. PMID: 20832198.
      View in: PubMed
    83. Heise LL, Watts C, Foss A, Trussell J, Vickerman P, Hayes R, McCormack S. Apples and oranges? Interpreting success in HIV prevention trials. Contraception. 2011 Jan; 83(1):10-5. PMID: 21134498.
      View in: PubMed
    84. Degenhardt L, Mathers B, Vickerman P, Rhodes T, Latkin C, Hickman M. Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed. Lancet. 2010 Jul 24; 376(9737):285-301. PMID: 20650522.
      View in: PubMed
    85. Rhodes T, Sarang A, Vickerman P, Hickman M. Policy resistance to harm reduction for drug users and potential effect of change. BMJ. 2010 Jul 13; 341:c3439. PMID: 20627977.
      View in: PubMed
    86. Pickles M, Foss AM, Vickerman P, Deering K, Verma S, Demers E, Washington R, Ramesh BM, Moses S, Blanchard J, Lowndes CM, Alary M, Reza-Paul S, Boily MC. Interim modelling analysis to validate reported increases in condom use and assess HIV infections averted among female sex workers and clients in southern India following a targeted HIV prevention programme. Sex Transm Infect. 2010 Feb; 86 Suppl 1:i33-43. PMID: 20167728.
      View in: PubMed
    87. Chandrashekar S, Guinness L, Kumaranayake L, Reddy B, Govindraj Y, Vickerman P, Alary M. The effects of scale on the costs of targeted HIV prevention interventions among female and male sex workers, men who have sex with men and transgenders in India. Sex Transm Infect. 2010 Feb; 86 Suppl 1:i89-94. PMID: 20167740.
      View in: PubMed
    88. Guinness L, Vickerman P, Quayyum Z, Foss A, Watts C, Rodericks A, Azim T, Jana S, Kumaranayake L. The cost-effectiveness of consistent and early intervention of harm reduction for injecting drug users in Bangladesh. Addiction. 2010 Feb; 105(2):319-28. PMID: 19922513.
      View in: PubMed
    89. Vickerman P, Hickman M, May M, Kretzschmar M, Wiessing L. Can hepatitis C virus prevalence be used as a measure of injection-related human immunodeficiency virus risk in populations of injecting drug users? An ecological analysis. Addiction. 2010 Feb; 105(2):311-8. PMID: 19922515.
      View in: PubMed
    90. Hickman M, Vickerman P, Macleod J, Lewis G, Zammit S, Kirkbride J, Jones P. If cannabis caused schizophrenia--how many cannabis users may need to be prevented in order to prevent one case of schizophrenia? England and Wales calculations. Addiction. 2009 Nov; 104(11):1856-61. PMID: 19832786.
      View in: PubMed
    91. Vickerman P, Ndowa F, O'Farrell N, Steen R, Alary M, Delany-Moretlwe S. Using mathematical modelling to estimate the impact of periodic presumptive treatment on the transmission of sexually transmitted infections and HIV among female sex workers. Sex Transm Infect. 2010 Jun; 86(3):163-8. PMID: 19854700.
      View in: PubMed
    92. Platt L, Sutton AJ, Vickerman P, Koshkina E, Maximova S, Latishevskaya N, Hickman M, Bonell C, Parry J, Rhodes T. Measuring risk of HIV and HCV among injecting drug users in the Russian Federation. Eur J Public Health. 2009 Aug; 19(4):428-33. PMID: 19349288.
      View in: PubMed
    93. Platt L, Vickerman P, Collumbien M, Hasan S, Lalji N, Mayhew S, Muzaffar R, Andreasen A, Hawkes S. Prevalence of HIV, HCV and sexually transmitted infections among injecting drug users in Rawalpindi and Abbottabad, Pakistan: evidence for an emerging injection-related HIV epidemic. Sex Transm Infect. 2009 Apr; 85 Suppl 2:ii17-22. PMID: 19307346.
      View in: PubMed
    94. Vickerman P, Platt L, Hawkes S. Modelling the transmission of HIV and HCV among injecting drug users in Rawalpindi, a low HCV prevalence setting in Pakistan. Sex Transm Infect. 2009 Apr; 85 Suppl 2:ii23-30. PMID: 19307347.
      View in: PubMed
    95. Foss AM, Vickerman PT, Chalabi Z, Mayaud P, Alary M, Watts CH. Dynamic modeling of herpes simplex virus type-2 (HSV-2) transmission: issues in structural uncertainty. Bull Math Biol. 2009 Apr; 71(3):720-49. PMID: 19219511.
      View in: PubMed
    96. Foss AM, Vickerman PT, Alary M, Watts CH. How much could a microbicide's sexually transmitted infection efficacy contribute to reducing HIV risk and the level of condom use needed to lower risk? Model estimates. Sex Transm Infect. 2009 Aug; 85(4):276-82. PMID: 19208696.
      View in: PubMed
    97. Deering KN, Vickerman P, Moses S, Ramesh BM, Blanchard JF, Boily MC. The impact of out-migrants and out-migration on the HIV/AIDS epidemic: a case study from south-west India. AIDS. 2008 Dec; 22 Suppl 5:S165-81. PMID: 19098476.
      View in: PubMed
    98. Boily MC, Pickles M, Vickerman P, Buzdugan R, Isac S, Deering KN, Blanchard JF, Moses S, Lowndes CM, Ramesh BM, Demers E, Alary M. Using mathematical modelling to investigate the plausibility of attributing observed antenatal clinic declines to a female sex worker intervention in Karnataka state, India. AIDS. 2008 Dec; 22 Suppl 5:S149-64. PMID: 19098475.
      View in: PubMed
    99. Hope V, Kimber J, Vickerman P, Hickman M, Ncube F. Frequency, factors and costs associated with injection site infections: findings from a national multi-site survey of injecting drug users in England. BMC Infect Dis. 2008 Sep 18; 8:120. PMID: 18801177.
      View in: PubMed
    100. Vickerman P, Foss A, Watts C. Using modeling to explore the degree to which a microbicide's sexually transmitted infection efficacy may contribute to the HIV effectiveness measured in phase 3 microbicide trials. J Acquir Immune Defic Syndr. 2008 Aug 01; 48(4):460-7. PMID: 18614928.
      View in: PubMed
    101. Vickerman P, Ndowa F, Mayaud P. Modelling the cost per ulcer treated of incorporating episodic treatment for HSV-2 into the syndromic algorithm for genital ulcer disease. Sex Transm Infect. 2008 Jun; 84(3):243-8. PMID: 18385226.
      View in: PubMed
    102. Boily MC, Lowndes CM, Vickerman P, Kumaranayake L, Blanchard J, Moses S, Ramesh BM, Pickles M, Watts C, Washington R, Reza-Paul S, Labbe AC, Anderson RM, Deering KN, Alary M. Evaluating large-scale HIV prevention interventions: study design for an integrated mathematical modelling approach. Sex Transm Infect. 2007 Dec; 83(7):582-9. PMID: 17942574.
      View in: PubMed
    103. Foss AM, Hossain M, Vickerman PT, Watts CH. A systematic review of published evidence on intervention impact on condom use in sub-Saharan Africa and Asia. Sex Transm Infect. 2007 Dec; 83(7):510-6. PMID: 17932124.
      View in: PubMed
    104. Fung IC, Guinness L, Vickerman P, Watts C, Vannela G, Vadhvana J, Foss AM, Malodia L, Gandhi M, Jani G. Modelling the impact and cost-effectiveness of the HIV intervention programme amongst commercial sex workers in Ahmedabad, Gujarat, India. BMC Public Health. 2007 Aug 06; 7:195. PMID: 17683595.
      View in: PubMed
    105. Hickman M, Vickerman P, Macleod J, Kirkbride J, Jones PB. Cannabis and schizophrenia: model projections of the impact of the rise in cannabis use on historical and future trends in schizophrenia in England and Wales. Addiction. 2007 Apr; 102(4):597-606. PMID: 17362293.
      View in: PubMed
    106. Vickerman P, Hickman M, Judd A. Modelling the impact on Hepatitis C transmission of reducing syringe sharing: London case study. Int J Epidemiol. 2007 Apr; 36(2):396-405. PMID: 17218325.
      View in: PubMed
    107. Foss AM, Watts CH, Vickerman P, Azim T, Guinness L, Ahmed M, Rodericks A, Jana S. Could the CARE-SHAKTI intervention for injecting drug users be maintaining the low HIV prevalence in Dhaka, Bangladesh? Addiction. 2007 Jan; 102(1):114-25. PMID: 17207129.
      View in: PubMed
    108. Vickerman P, Peeling RW, Terris-Prestholt F, Changalucha J, Mabey D, Watson-Jones D, Watts C. Modelling the cost-effectiveness of introducing rapid syphilis tests into an antenatal syphilis screening programme in Mwanza, Tanzania. Sex Transm Infect. 2006 Dec; 82 Suppl 5:v38-43. PMID: 17215276.
      View in: PubMed
    109. Aledort JE, Ronald A, Rafael ME, Girosi F, Vickerman P, Le Blancq SM, Landay A, Holmes K, Ridzon R, Hellmann N, Shea MV, Peeling RW. Reducing the burden of sexually transmitted infections in resource-limited settings: the role of improved diagnostics. Nature. 2006 Nov 23; 444 Suppl 1:59-72. PMID: 17159895.
      View in: PubMed
    110. Vickerman P, Kumaranayake L, Balakireva O, Guinness L, Artyukh O, Semikop T, Yaremenko O, Watts C. The cost-effectiveness of expanding harm reduction activities for injecting drug users in Odessa, Ukraine. Sex Transm Dis. 2006 Oct; 33(10 Suppl):S89-102. PMID: 16735956.
      View in: PubMed
    111. Williams JR, Foss AM, Vickerman P, Watts C, Ramesh BM, Reza-Paul S, Washington RG, Moses S, Blanchard J, Lowndes CM, Alary M, Boily MC. What is the achievable effectiveness of the India AIDS Initiative intervention among female sex workers under target coverage? Model projections from southern India. Sex Transm Infect. 2006 Oct; 82(5):372-80. PMID: 17012512.
      View in: PubMed
    112. Vickerman P, Watts C, Peeling RW, Mabey D, Alary M. Modelling the cost effectiveness of rapid point of care diagnostic tests for the control of HIV and other sexually transmitted infections among female sex workers. Sex Transm Infect. 2006 Oct; 82(5):403-12. PMID: 17012515.
      View in: PubMed
    113. Vickerman P, Terris-Prestholt F, Delany S, Kumaranayake L, Rees H, Watts C. Are targeted HIV prevention activities cost-effective in high prevalence settings? Results from a sexually transmitted infection treatment project for sex workers in Johannesburg, South Africa. Sex Transm Dis. 2006 Oct; 33(10 Suppl):S122-32. PMID: 16735954.
      View in: PubMed
    114. Vickerman P, Hickman M, Rhodes T, Watts C. Model projections on the required coverage of syringe distribution to prevent HIV epidemics among injecting drug users. J Acquir Immune Defic Syndr. 2006 Jul; 42(3):355-61. PMID: 16645549.
      View in: PubMed
    115. Vickerman P, Watts C, Delany S, Alary M, Rees H, Heise L. The importance of context: model projections on how microbicide impact could be affected by the underlying epidemiologic and behavioral situation in 2 African settings. Sex Transm Dis. 2006 Jun; 33(6):397-405. PMID: 16721331.
      View in: PubMed
    116. Foss AM, Watts CH, Vickerman PT, Heise L. Care should be taken when promoting microbicide use among sex workers who are able to use condoms consistently: response to Smith et al. (2005). AIDS. 2006 Jan 09; 20(2):303-5. PMID: 16511432.
      View in: PubMed
    117. Hongoro C, McPake B, Vickerman P. Measuring the quality of hospital tuberculosis services: a prospective study in four Zimbabwe hospitals. Int J Qual Health Care. 2005 Aug; 17(4):287-92. PMID: 15831546.
      View in: PubMed
    118. Vickerman P, Peeling RW, Watts C, Mabey D. Detection of gonococcal infection : pros and cons of a rapid test. Mol Diagn. 2005; 9(4):175-9. PMID: 16392895.
      View in: PubMed
    119. Kumaranayake L, Vickerman P, Walker D, Samoshkin S, Romantzov V, Emelyanova Z, Zviagin V, Watts C. The cost-effectiveness of HIV preventive measures among injecting drug users in Svetlogorsk, Belarus. Addiction. 2004 Dec; 99(12):1565-76. PMID: 15585048.
      View in: PubMed
    120. Foss AM, Watts CH, Vickerman P, Heise L. Condoms and prevention of HIV. BMJ. 2004 Jul 24; 329(7459):185-6. PMID: 15271806.
      View in: PubMed
    121. Vickerman P, Watts C, Alary M, Mabey D, Peeling RW. Sensitivity requirements for the point of care diagnosis of Chlamydia trachomatis and Neisseria gonorrhoeae in women. Sex Transm Infect. 2003 Oct; 79(5):363-7. PMID: 14573829.
      View in: PubMed
    122. Foss AM, Vickerman PT, Heise L, Watts CH. Shifts in condom use following microbicide introduction: should we be concerned? AIDS. 2003 May 23; 17(8):1227-37. PMID: 12819525.
      View in: PubMed
    123. Vahey M, Nau ME, Barrick S, Cooley JD, Sawyer R, Sleeker AA, Vickerman P, Bloor S, Larder B, Michael NL, Wegner SA. Performance of the Affymetrix GeneChip HIV PRT 440 platform for antiretroviral drug resistance genotyping of human immunodeficiency virus type 1 clades and viral isolates with length polymorphisms. J Clin Microbiol. 1999 Aug; 37(8):2533-7. PMID: 10405396.
      View in: PubMed
    Vickerman's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description